GLENN SBLENDORIO

Insider Reports History

Location
Princeton, NJ
Signature
/s/ Scott Bizily as Attorney-in-Fact for Glenn Sblendorio
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by GLENN SBLENDORIO:

Company Role Class Num Shares Value Price $ Report Date Ownership
AMICUS THERAPEUTICS, INC. Director Common Stock 115,857 $719,471 $6.21 05 Jun 2025 Direct
AMICUS THERAPEUTICS, INC. Director Stock Options (right to buy) 74,872 05 Jun 2025 Direct
4D Molecular Therapeutics, Inc. Director Stock Option (Right to Buy) 45,000 05 Jan 2026 Direct
AMICUS THERAPEUTICS, INC. Director Stock Options (right to buy) 42,467 06 Jun 2024 Direct
Mineralys Therapeutics, Inc. Director Stock Option 32,900 13 Feb 2025 Direct
Mineralys Therapeutics, Inc. Director Stock Option 22,000 22 May 2024 Direct
INTERCEPT PHARMACEUTICALS, INC. Director Common Stock 0 $19.00 08 Nov 2023 Direct
INTERCEPT PHARMACEUTICALS, INC. Director Option to Purchase Common Stock 0 08 Nov 2023 Direct
IVERIC bio, Inc. Chief Executive Officer, Director Common Stock 0 $39.45 11 Jul 2023 Direct
IVERIC bio, Inc. Chief Executive Officer, Director Restricted Stock Units 0 11 Jul 2023 Direct
IVERIC bio, Inc. Chief Executive Officer, Director Stock Option (Right to Buy) 0 $10.03 11 Jul 2023 Direct

Insider Reports Filed by GLENN SBLENDORIO

Symbol Company Period Transactions Value $ Form Type Role Filing Time
FDMT 4D Molecular Therapeutics, Inc. 05 Jan 2026 1 $0 4 Director 07 Jan 2026, 21:12
FDMT 4D Molecular Therapeutics, Inc. 05 Jan 2026 0 $0 3 Director 07 Jan 2026, 21:10
FOLD AMICUS THERAPEUTICS, INC. 05 Jun 2025 2 $0 4 Director 06 Jun 2025, 16:58
MLYS Mineralys Therapeutics, Inc. 13 Feb 2025 1 $0 4 Director 24 Feb 2025, 18:58
FOLD AMICUS THERAPEUTICS, INC. 06 Jun 2024 2 $0 4 Director 07 Jun 2024, 19:46
MLYS Mineralys Therapeutics, Inc. 22 May 2024 1 $0 4 Director 23 May 2024, 16:22
FOLD AMICUS THERAPEUTICS, INC. 07 Mar 2024 2 +$42,000 4 Director 11 Mar 2024, 17:36
/report/000110465923117109-sblendorio-glenn-2023-11-08 INTERCEPT PHARMACEUTICALS, INC. 08 Nov 2023 12 -$599,602 4 Director 13 Nov 2023, 14:45
MLYS Mineralys Therapeutics, Inc. 13 Sep 2023 1 $0 4 Director 14 Sep 2023, 16:13
MLYS Mineralys Therapeutics, Inc. 13 Sep 2023 0 $0 3 Director 14 Sep 2023, 16:13
/report/000110465923080686-sblendorio-glenn-2023-07-11 IVERIC bio, Inc. 11 Jul 2023 16 $0 4 Chief Executive Officer, Director 13 Jul 2023, 13:59
/report/000141093923000099-sblendorio-glenn-2023-06-22 IVERIC bio, Inc. 22 Jun 2023 2 +$146,486 4 Chief Executive Officer, Director 26 Jun 2023, 16:44
FOLD AMICUS THERAPEUTICS, INC. 08 Jun 2023 2 $0 4 Director 12 Jun 2023, 17:37
/report/000110465923064845-sblendorio-glenn-2023-05-24 INTERCEPT PHARMACEUTICALS, INC. 24 May 2023 2 $0 4 Director 25 May 2023, 20:40
FOLD AMICUS THERAPEUTICS, INC. 18 May 2023 2 +$49,800 4 Director 19 May 2023, 17:13
/report/000141093923000008-sblendorio-glenn-2023-01-02 IVERIC bio, Inc. 02 Jan 2023 3 -$349,987 4 Chief Executive Officer, Director 04 Jan 2023, 17:34
/report/000141093922000152-sblendorio-glenn-2022-12-27 IVERIC bio, Inc. 27 Dec 2022 1 $0 4 Chief Executive Officer, Director 29 Dec 2022, 15:50
/report/000141093922000150-sblendorio-glenn-2022-12-20 IVERIC bio, Inc. 20 Dec 2022 2 $0 4 Chief Executive Officer, Director 22 Dec 2022, 17:56
/report/000141093922000138-sblendorio-glenn-2022-12-18 IVERIC bio, Inc. 18 Dec 2022 3 -$418,520 4 CEO, Director 20 Dec 2022, 18:02
/report/000141093922000126-sblendorio-glenn-2022-12-09 IVERIC bio, Inc. 09 Dec 2022 4 $0 4 CEO, Director 13 Dec 2022, 20:01
/report/000141093922000110-sblendorio-glenn-2022-11-02 IVERIC bio, Inc. 02 Nov 2022 1 -$1,150,500 4 CEO, Director 04 Nov 2022, 17:01
FOLD AMICUS THERAPEUTICS, INC. 09 Jun 2022 2 $0 4 Director 10 Jun 2022, 16:12
/report/000110465922065913-sblendorio-glenn-2022-05-25 INTERCEPT PHARMACEUTICALS, INC. 25 May 2022 2 $0 4 Director 27 May 2022, 16:18
/report/000141093922000048-sblendorio-glenn-2022-04-04 IVERIC bio, Inc. 04 Apr 2022 1 -$937,805 4 CEO, Director 06 Apr 2022, 18:11
/report/000141093922000040-sblendorio-glenn-2022-03-30 IVERIC bio, Inc. 30 Mar 2022 9 -$630,179 4 CEO, Director 01 Apr 2022, 19:03
/report/000141093922000031-sblendorio-glenn-2022-03-25 IVERIC bio, Inc. 25 Mar 2022 3 -$265,103 4 CEO, Director 29 Mar 2022, 19:44
/report/000141093922000023-sblendorio-glenn-2022-03-18 IVERIC bio, Inc. 18 Mar 2022 3 -$48,917 4 CEO, Director 22 Mar 2022, 16:43
FOLD AMICUS THERAPEUTICS, INC. 04 Mar 2022 2 +$71,850 4 Director 07 Mar 2022, 16:54
/report/000110465922000502-sblendorio-glenn-2021-12-30 IVERIC bio, Inc. 30 Dec 2021 6 -$12,673 4 CEO, Director 03 Jan 2022, 16:58
/report/000110465921153685-sblendorio-glenn-2021-12-22 IVERIC bio, Inc. 22 Dec 2021 14 -$882,488 4 CEO, Director 27 Dec 2021, 19:58
/report/000110465921152293-sblendorio-glenn-2021-12-18 IVERIC bio, Inc. 18 Dec 2021 3 -$286,075 4 CEO, Director 21 Dec 2021, 17:02
/report/000110465921151719-sblendorio-glenn-2021-12-16 IVERIC bio, Inc. 16 Dec 2021 2 $0 4 Chief Executive Officer, Director 20 Dec 2021, 15:32
/report/000110465921149631-sblendorio-glenn-2021-12-12 IVERIC bio, Inc. 12 Dec 2021 3 -$122,279 4 Chief Executive Officer, Director 14 Dec 2021, 17:07
/report/000110465921149246-sblendorio-glenn-2021-12-09 IVERIC bio, Inc. 09 Dec 2021 2 $0 4 Chief Executive Officer, Director 13 Dec 2021, 18:50
FOLD AMICUS THERAPEUTICS, INC. 10 Jun 2021 2 $0 4 Director 14 Jun 2021, 19:13
/report/000110465921075223-sblendorio-glenn-2021-05-27 INTERCEPT PHARMACEUTICALS, INC. 27 May 2021 2 $0 4 Director 01 Jun 2021, 19:03